Biomarkers in neonatal encephalopathy: the role of high-mobility group box 1 in prognosis and potential therapy. Molloy EJ. Pediatr Res 2025 Sep 10. doi: 10.1038/s41390-025-04309.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Molloy EJ. Biomarkers in neonatal encephalopathy: the role of high-mobility group box 1 in prognosis and potential therapy. Pediatr Res 2025 Sep 10. doi: 10.1038/s41390-025-04309.
PMID: 40931116